Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-06-23 Purchase |
2021-06-23 5:12 pm |
Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner |
10,000 | $7.6716 | $76,716 | 1,638,235 (Indirect Direct) |
View |
2021-06-22 Purchase |
2021-06-22 6:07 pm |
Processa Pharmaceuticals Inc. | PCSA | Floyd Robert Michael Chief Operating Officer |
2,000 | $7.0292 | $14,058 | 131,851 (Indirect Direct) |
View |
2021-06-21 Purchase |
2021-06-22 5:13 pm |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
2,000 | $6.65 | $13,300 | 401,737 (Direct) |
View |
2021-06-21 Purchase |
2021-06-22 5:09 pm |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
1,000 | $6.81 | $6,810 | 36,510 (Direct) |
View |
2021-04-06 Sale(A) |
2021-05-05 12:53 pm |
Processa Pharmaceuticals Inc. | PCSA | BESSER JAMES E See Remarks |
447,771 | $10.77 | $4,821,342 | 1,053,300 (Indirect Direct) |
View |
2021-02-18 Sale(A) |
2021-05-05 12:13 pm |
Processa Pharmaceuticals Inc. | PCSA | BESSER JAMES E 10% Owner |
28,929 | $11.49 | $332,289 | 1,501,071 (Indirect Direct) |
View |
2021-04-13 Sale |
2021-04-15 4:33 pm |
Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director |
16,200 | $9.5965 | $155,464 | 548,978 (Indirect Direct) |
View |
2021-04-06 Sale |
2021-04-08 6:05 pm |
Processa Pharmaceuticals Inc. | PCSA | BESSER JAMES E See Remarks |
447,771 | $10.77 | $4,821,342 | 1,053,300 (Indirect Direct) |
View |
2021-02-18 Sale |
2021-02-22 8:13 pm |
Processa Pharmaceuticals Inc. | PCSA | BESSER JAMES E 10% Owner |
28,929 | $11.49 | $332,289 | 1,501,071 (Indirect Direct) |
View |
2020-10-02 Purchase |
2020-10-13 6:33 pm |
Processa Pharmaceuticals Inc. | PCSA | BESSER JAMES E 10% Owner |
30,000 | $4.04 | $121,200 | 1,530,000 (Indirect Direct) |
View |
2020-10-01 Purchase(A) |
2020-10-05 5:33 pm |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
6,000 | $4 | $24,000 | 47,248 (Direct) |
View |
2020-10-01 Purchase(A) |
2020-10-05 5:31 pm |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
31,250 | $4 | $125,000 | 399,737 (Direct) |
View |
2020-10-01 Purchase |
2020-10-05 4:43 pm |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
6,000 | $2.1 | $12,600 | 47,248 (Direct) |
View |
2020-10-01 Purchase |
2020-10-05 4:42 pm |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
31,250 | $2.1 | $65,625 | 399,737 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-08-05 Option Award |
2021-08-09 4:35 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | THOMPSON VIRGIL Director |
1,169 | $0 | 93,136 (Direct) |
View |
2021-08-05 Option Award |
2021-08-09 4:33 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner |
7,601 | $0 | 1,687,627 (Direct) |
View |
2021-07-08 Option Award |
2021-07-09 4:47 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Floyd Robert Michael Chief Operating Officer |
23,337 | $0 | 31,464 (Direct) |
View |
2021-07-08 Option Award |
2021-07-09 4:42 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer |
23,337 | $0 | 31,464 (Direct) |
View |
2021-07-08 Option Award |
2021-07-09 4:39 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
23,337 | $0 | 31,464 (Direct) |
View |
2021-07-08 Option Award |
2021-07-09 4:34 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer |
23,337 | $0 | 31,464 (Direct) |
View |
2021-07-08 Option Award |
2021-07-09 4:33 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner |
23,337 | $0 | 31,464 (Direct) |
View |
2021-07-08 Option Award |
2021-07-09 4:31 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
23,337 | $0 | 31,464 (Direct) |
View |
2021-06-08 Option Award |
2021-06-10 5:14 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Guy Wendy Chief Administrative Officer |
8,127 | $0 | 8,127 (Direct) |
View |
2021-06-08 Option Award |
2021-06-10 5:13 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Bigora Sian Chief Development Officer |
8,127 | $0 | 8,127 (Direct) |
View |
2021-06-08 Option Award |
2021-06-10 5:11 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
8,127 | $0 | 8,127 (Direct) |
View |
2021-06-08 Option Award |
2021-06-10 5:09 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Floyd Robert Michael Chief Operating Officer |
8,127 | $0 | 8,127 (Direct) |
View |
2021-06-08 Option Award |
2021-06-10 5:06 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
8,127 | $0 | 8,127 (Direct) |
View |
2021-06-08 Option Award |
2021-06-10 5:04 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer 10% Owner |
8,127 | $0 | 8,127 (Direct) |
View |
Ownership |
2020-11-13 4:27 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Islam Khalid Director |
0 | $0 | 189,259 (Indirect) |
View |
Ownership |
2020-10-16 4:40 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Floyd Robert Michael Chief Operating Officer |
0 | $0 | 129,851 (Direct) |
View |
Ownership |
2020-10-13 6:22 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | BESSER JAMES E 10% Owner |
0 | $0 | 1,500,000 (Direct) |
View |
Ownership(A) |
2020-10-05 09:15 am |
2018-06-29 2021-06-29 |
Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer |
0 | $0 | 53,921 (Direct) |
View |
Ownership(A) |
2020-10-05 09:13 am |
2018-05-25 2021-05-25 |
Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director |
0 | $0 | 73,657 (Indirect) |
View |
Ownership(A) |
2020-10-05 09:12 am |
2018-06-29 2021-06-29 |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
0 | $0 | 4,469 (Direct) |
View |
Ownership |
2020-10-02 4:52 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Young David Chief Executive Officer |
0 | $0 | 1,698,679 (Direct) |
View |
Ownership |
2020-10-02 4:51 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Yorke Justin W Director |
0 | $0 | 640,903 (Direct) |
View |
Ownership |
2020-10-02 4:50 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | THOMPSON VIRGIL Director |
0 | $0 | 92,765 (Direct) |
View |
Ownership |
2020-10-02 4:46 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Stanker James H Chief Financial Officer |
0 | $0 | 105,543 (Direct) |
View |
Ownership |
2020-10-02 4:41 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Pannu Geraldine Director |
0 | $0 | 3,268 (Direct) |
View |
Ownership |
2020-10-02 4:38 pm |
N/A N/A |
Processa Pharmaceuticals Inc. | PCSA | Lin Patrick Chief Business - Strategy Off |
0 | $0 | 389,479 (Direct) |
View |